Merck KGaA, Darmstadt, Germany
merckgroup.comTotal trials
275
Active
0
Phase 3
42
Total enrollment
85,269
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Infertility29
- Multiple Sclerosis23
- Healthy21
- Growth Disorders20
- Multiple Sclerosis, Relapsing-Remitting11
- Hypertension9
- Ovulation Induction9
- Metastatic Colorectal Cancer5
Frequently asked questions about Merck KGaA, Darmstadt, Germany
- How many clinical trials does Merck KGaA, Darmstadt, Germany have on ClinicalTrials.gov?
- Merck KGaA, Darmstadt, Germany is listed as the lead sponsor on 275 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Merck KGaA, Darmstadt, Germany's trials are in Phase 3?
- 42 of Merck KGaA, Darmstadt, Germany's trials are in Phase 3.
- What therapeutic areas does Merck KGaA, Darmstadt, Germany focus on?
- Merck KGaA, Darmstadt, Germany's most-studied conditions on ClinicalTrials.gov are Infertility, Multiple Sclerosis, Healthy, Growth Disorders, Multiple Sclerosis, Relapsing-Remitting.